Comparatively to the HFD/STZ-induced T2DM mice, surfactin treatment in the present study significantly increased the colon levels of Occludin and Claudin-1, further reducing intestinal permeability. The gene discussed is OCLN; the disease is type 2 diabetes mellitus.